Cubist Systematic Strategies LLC Buys 1,085 Shares of Orthofix Medical Inc (NASDAQ:OFIX)

Cubist Systematic Strategies LLC raised its stake in shares of Orthofix Medical Inc (NASDAQ:OFIX) by 21.4% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,149 shares of the medical device company’s stock after buying an additional 1,085 shares during the period. Cubist Systematic Strategies LLC’s holdings in Orthofix Medical were worth $325,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Marshall Wace North America L.P. bought a new position in Orthofix Medical during the first quarter valued at about $25,000. Tower Research Capital LLC TRC bought a new position in Orthofix Medical during the second quarter valued at about $54,000. Quantamental Technologies LLC raised its holdings in Orthofix Medical by 14,277.8% during the second quarter. Quantamental Technologies LLC now owns 1,294 shares of the medical device company’s stock valued at $68,000 after buying an additional 1,285 shares in the last quarter. Congress Asset Management Co. MA bought a new position in Orthofix Medical during the second quarter valued at about $234,000. Finally, Paloma Partners Management Co bought a new position in Orthofix Medical during the second quarter valued at about $244,000. Institutional investors own 94.80% of the company’s stock.

Several equities research analysts have recently issued reports on OFIX shares. Zacks Investment Research downgraded Orthofix Medical from a “buy” rating to a “hold” rating in a research report on Friday, August 9th. BidaskClub downgraded Orthofix Medical from a “hold” rating to a “sell” rating in a research report on Friday. One analyst has rated the stock with a sell rating, three have assigned a hold rating and one has assigned a buy rating to the company. The company presently has a consensus rating of “Hold” and an average price target of $59.50.

In other news, CEO Brad Mason sold 5,805 shares of the firm’s stock in a transaction dated Wednesday, August 28th. The stock was sold at an average price of $50.97, for a total value of $295,880.85. Following the sale, the chief executive officer now directly owns 165,041 shares of the company’s stock, valued at $8,412,139.77. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Company insiders own 5.80% of the company’s stock.

Shares of NASDAQ:OFIX opened at $52.08 on Friday. The company has a market cap of $992.96 million, a P/E ratio of 26.57, a P/E/G ratio of 2.84 and a beta of 0.41. The stock’s 50-day moving average is $51.42 and its 200-day moving average is $52.41. Orthofix Medical Inc has a 52-week low of $47.79 and a 52-week high of $74.44. The company has a debt-to-equity ratio of 0.06, a quick ratio of 2.26 and a current ratio of 3.42.

Orthofix Medical (NASDAQ:OFIX) last issued its quarterly earnings results on Monday, August 5th. The medical device company reported $0.28 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.40 by ($0.12). The business had revenue of $115.85 million during the quarter, compared to analyst estimates of $115.17 million. Orthofix Medical had a net margin of 1.75% and a return on equity of 9.50%. The company’s revenue for the quarter was up 3.9% compared to the same quarter last year. During the same period in the prior year, the business posted $0.42 earnings per share. As a group, equities analysts predict that Orthofix Medical Inc will post 1.77 EPS for the current year.

Orthofix Medical Company Profile

Orthofix Medical Inc, a medical device company, provides musculoskeletal healing products and therapies worldwide. It operates through four segments: Bone Growth Therapies, Spinal Implants, Biologics, and Orthofix Extremities. The Bone Growth Therapies segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion and are indicated as treatment to enhance fusion success rates in cervical and lumbar spine, as well as a therapeutic treatment for non-spinal appendicular fractures.

Further Reading: Holder of Record

Want to see what other hedge funds are holding OFIX? Visit to get the latest 13F filings and insider trades for Orthofix Medical Inc (NASDAQ:OFIX).

Institutional Ownership by Quarter for Orthofix Medical (NASDAQ:OFIX)

Receive News & Ratings for Orthofix Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthofix Medical and related companies with's FREE daily email newsletter.